Friday, May 10, 2024 11:27:19 AM
"I can tell you, Clone3 and Clone7 are working well and are successes, a new test market will begin getting volunteer trials, but not anything like the old one that had the same BS story over it, and it's not where you might think. Should be the final magnet to close negotiations that are already underway.
They even seem confident that Harry will be gone at that time. That I found interesting. They no longer sound as wildly stressed as they did just 2 weeks back."
What you posted is BS - post your proof that Clone3 and Clone7 are successes.
Where are they conducting Clinical Trials - where are the results from the clinical trials?
You wrote: "Clone3 and Clone7 are working well and are successes, a new test market will begin getting volunteer trials"
A new test market will begin getting volunteer trials. That is meaningless jibberish - you are just pumping.
IG
The First Casualty of Emotion is Reason.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM